A GLP-1 receptor agonist, Semaglutide has emerged as a transformative therapy for Type 2 diabetes and weight management, driven by strong outcomes in glycemic control and weight reduction, it said
Experimental procedures were approved under AUP#2909 and AUP#2029 by the University of Ottawa Animal Care and Veterinary Service (Ottawa, Ontario, Canada)
For a deeper dive into the muscle loss data and complete lean mass protection strategy, see my GLP-1 muscle loss guide
In clinical trials, theyve been shown to help people lose up to 20.9% on average after 72 weeks (after treatment with the 15mg dose of Zepbound)
1 mM MgSO 4 , 120 M KH 2 PO 4 , 74 M Na 2 HPO 4 , 1 mM CaCl 2 , 500 M KCl, 15 mM NaCl, and 500 M NaHCO 3 in dH 2 O
Thrilled Rated 5 out of 5 Mitch Lost 10% of my weight